Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:21 AM
Ignite Modification Date:
2025-12-25 @ 2:21 AM
NCT ID:
NCT04361734
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of SLE according to American College of Rheumatology revised criteria
* Having given written informed consent prior to undertaking any study-related procedures.
* Male and female patients between the ages of 18 and 80 years.
Patients who have met all the above inclusion criteria listed and healthy donors will be screened for the following exclusion criteria:
Exclusion Criteria:
* Under any administrative or legal supervision.
* Conditions/situations such as:
* A concomitant autoimmune disease
* Impossibility to meet specific protocol requirements (e.g. blood sampling).
* Patient is the Investigator or any sub-investigator, research assistant, pharmacist, study coordinator, other staff or relative thereof directly involved in the conduct of the protocol.
* Uncooperative or any condition that could make the patient potentially non-compliant to the study procedures.
* Pregnant or breast-feeding women, currently or in the last three months prior to inclusion.
* Patients who have been vaccinated in the last three months prior to inclusion.
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT04361734
Study Brief:
Protocol Section:
NCT04361734